0001415889-24-002873.txt : 20240206 0001415889-24-002873.hdr.sgml : 20240206 20240206214710 ACCESSION NUMBER: 0001415889-24-002873 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coen Stacy Ann CENTRAL INDEX KEY: 0001814150 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 24601930 MAIL ADDRESS: STREET 1: 11 RUSH POND RD CITY: LAKEVILLE STATE: MA ZIP: 02347 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoGen, Inc. CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGEN INC DATE OF NAME CHANGE: 19920703 4 1 form4-02072024_020202.xml X0508 4 2024-02-02 0000855654 ImmunoGen, Inc. IMGN 0001814150 Coen Stacy Ann C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451 false true false false SVP & CHIEF BUSINESS OFFICER 1 Common Stock 2024-02-02 4 M 0 14350 0 A 77857 D Common Stock 2024-02-05 4 S 0 4583 29.30 D 73274 D Restricted Stock Unit 0 2024-02-02 4 M 0 14350 0 D Common Stock 14350 28700 D Effected pursuant to a trading plan adopted on June 15, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The RSUs were awarded on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date. /s/ Renee Lentini, Attorney-in-Fact 2024-02-06